Vial Announces Collaborative Alliance with MLM Medical Labs

16 September 2023

Vial, a global Contract Research Organization (CRO) specializing in cutting-edge clinical trial management services, has formed a strategic partnership with MLM Medical Labs ("MLM"), an international central and specialized laboratory with facilities spanning Europe and North America. Under this collaboration, MLM will provide Vial with comprehensive central laboratory solutions, encompassing study setup management, sample analysis, and their exclusive MLM Kit Building® service, featuring tailored all-in-one sample collection kits, tracking barcodes, and color-coded labeling solutions, among other offerings.

MLM further augments its offerings with a complete sample management solution and a secure, real-time clinical data portal through its proprietary MLM Sample Storage System® and MLM-Online® platforms. For clients requiring point-of-collection sample tracking, MLM has joined forces with TruLab, Inc. to furnish biopharmaceutical companies and Contract Research Organizations (CROs) with precise sample location information from collection sites, real-time monitoring of protocol deviations, informed consent tracking, and the harmonization of specimen data. This integrated suite of cutting-edge technologies offers invaluable resources not only to trial sponsors and CROs but also to site staff, Clinical Research Associates (CRAs), medical monitors, and project managers.

Simon Burns, CEO and Co-Founder of Vial, expressed enthusiasm about the partnership, stating, "We're excited to collaborate with the MLM team, who will assist us in delivering top-quality and highly efficient central laboratory solutions to our sponsors. MLM's products eliminate paper-based workflows, alleviating the burdens of data entry and other repetitive tasks for site staff."

Vial is committed to delivering faster and more efficient trials to biotechnology sponsors at a competitive rate. Setting itself apart in the CRO landscape, Vial leverages digital technology, including its TrialOS platform, which seamlessly integrates eSource, Electronic Data Capture (EDC), and Electronic Patient-Reported Outcomes (ePRO) into a unified system, streamlining site processes. Vial's EDC platform offers a contemporary, user-friendly, and highly responsive experience, delivering next-generation performance in eClinical software. These best-in-class CRO services, combined with strategic partnerships like the one with MLM, contribute to expediting the development of novel therapies and devices for sponsors and patients alike.

MLM CEO Scott Houlton expressed his enthusiasm for the integrated partnership, stating, "MLM is thrilled to join forces with Vial. We eagerly anticipate assisting Vial in delivering swifter and more efficient trials for biopharmaceutical sponsors. Collaborations such as this enable partners to work more intelligently, merging their distinct expertise in clinical research with cutting-edge information technology, allowing investigators and staff to focus on subjects. This reduction in queries and costly errors ultimately saves valuable time and resources."

 

Source: prnewswire.com